Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pdl Biopharma Inc (PDLI)

Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pdl Biopharma Inc 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 USA

www.pdl.com P: 775-832-8500

Description:

Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.

Key Statistics

Overview:

Market Capitalization, $K 282,141
Shares Outstanding, K 114,227
Annual Sales, $ 54,760 K
Annual Net Income, $ -70,410 K
Last Quarter Sales, $ 4,120 K
Last Quarter Net Income, $ 4,400 K
60-Month Beta 1.11
% of Insider Shareholders 2.20%
% of Institutional Shareholders 75.33%
Float, K 111,714
% Float 97.80%

Growth:

1-Year Return -24.00%
3-Year Return -13.03%
5-Year Return -24.23%
5-Year Revenue Growth -90.58%
5-Year Earnings Growth -85.19%
5-Year Dividend Growth -100.00%

Per-Share Information:

Latest Earnings Date 12/31/21
Earnings Per Share ttm -0.46
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.050 on 06/02/16
Next Ex-Dividends Date 09/21/20
Dividend Payable Date 10/01/20
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 10/10/01

PDLI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.04%
Return-on-Assets % -8.29%
Profit Margin % -128.58%
Debt/Equity 0.03
Price/Sales 5.63
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -5.47

PDLI Dividends

Date Value
06/02/16 $0.0500
03/02/16 $0.0500
12/02/15 $0.1500
09/02/15 $0.1500
06/03/15 $0.1500
03/03/15 $0.1500
12/03/14 $0.1500
09/03/14 $0.1500
06/03/14 $0.1500
03/03/14 $0.1500
12/03/13 $0.1500
09/03/13 $0.1500
06/03/13 $0.1500
03/01/13 $0.1500
12/05/12 $0.1500
09/05/12 $0.1500
06/05/12 $0.1500
03/05/12 $0.1500
12/06/11 $0.1500
09/06/11 $0.1500
06/06/11 $0.1500
03/04/11 $0.1500
09/13/10 $0.5000
03/11/10 $0.5000
11/27/09 $1.6700
09/15/09 $0.5000
03/12/09 $0.5000
12/19/08 $2.6000
05/06/08 $4.2500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar